Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EBM TechnologiesROCO:8409 63 Earnings Yield (Joel Greenblatt) % is 6.36% as of Jun. 2026. GuruFocus rates ROCO:8409 with a GF Score™ of 63/100 and a GF Value™ of NT$25.02 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 681 Healthcare Providers & Services companies, EBM Technologies ranks better than 72.25% on this metric.
EBM Technologies's Enterprise Value for the quarter that ended in Jun. 2026 was NT$559.6 Mil.
EBM Technologies's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 was NT$38.7 Mil. EBM Technologies's Earnings Yield (Joel Greenblatt) for the quarter that ended in Jun. 2026 was 6.36%.
The historical rank and industry rank for EBM Technologies's Earnings Yield (Joel Greenblatt) % or its related term are showing as below:
ROCO:8409'
s Earnings Yield (Joel Greenblatt) % Range Over the Past 10 Years
Min: -13.35 Med: -3.97 Max: 8.19
Current: 7.46
During the past 13 years, the highest Earnings Yield (Joel Greenblatt) of EBM Technologies was 8.19%. The lowest was -13.35%. And the median was -3.97%.
ROCO:8409's Earnings Yield (Joel Greenblatt) % is ranked better than 72.25% of 681
companies
in the Healthcare Providers & Services industry
Industry Median: 3.92
vs ROCO:8409: 7.46
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. EBM Technologies's Forward Rate of Return (Yacktman) % for the quarter that ended in Jun. 2026 was 0.00%. The Forward Rate of Return uses the normalized Free Cash Flow of the past five years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.
Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.
Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.
Be Aware
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
EBM Technologies Earnings Yield (Joel Greenblatt) % Related Terms
EBM Technologies Earnings Yield (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for EBM Technologies's Earnings Yield (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, EBM Technologies's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
EBM Technologies Earnings Yield (Joel Greenblatt) % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, EBM Technologies's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where EBM Technologies's Earnings Yield (Joel Greenblatt) % falls into.
In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.
EBM Technologiess Earnings Yield (Joel Greenblatt) for the fiscal year that ended in Dec. 2025 is calculated as
EBM Technologies's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$38.7 Mil.
What does a Earnings Yield (Joel Greenblatt) % of 6.36% mean?
EBM Technologies (ROCO:8409) has a Earnings Yield (Joel Greenblatt) % of 6.36% as of Jun. 2026. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on EBM Technologies and its competitors. According to the industry distribution chart, EBM Technologies ranks #189 out of 681 companies in the Healthcare Providers & Services industry, placing it in the top 27.8%.
Is EBM Technologies' Earnings Yield (Joel Greenblatt) % too high?
EBM Technologies' current Earnings Yield (Joel Greenblatt) % is 6.36%. The Healthcare Providers & Services industry median Earnings Yield (Joel Greenblatt) % is 3.92. EBM Technologies' value of 6.36% is 62.2% above this industry median. Based on the distribution chart, EBM Technologies ranks #189 out of 681 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, EBM Technologies has a GF Score™ of 63/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does EBM Technologies' Earnings Yield (Joel Greenblatt) % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, EBM Technologies ranks #189 out of 681 companies for Earnings Yield (Joel Greenblatt) %. This puts EBM Technologies in the upper half of its industry. The industry median Earnings Yield (Joel Greenblatt) % is 3.92. EBM Technologies' value of 6.36% is 62.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings Yield (Joel Greenblatt) % for a Healthcare Providers & Services company?
The median Earnings Yield (Joel Greenblatt) % among Healthcare Providers & Services companies is 3.92, based on 681 companies in the industry. Companies in the top quartile (top 25%) have a Earnings Yield (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, Earnings Yield (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. EBM Technologies's current Earnings Yield (Joel Greenblatt) % of 6.36% is 62.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings Yield (Joel Greenblatt) % mean?
A high Earnings Yield (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on EBM Technologies and its competitors. For the Healthcare Providers & Services industry, the median Earnings Yield (Joel Greenblatt) % is 3.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. EBM Technologies's current Earnings Yield (Joel Greenblatt) % is 6.36%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EBM Technologies stock overvalued right now?
Based on GuruFocus' analysis, EBM Technologies (ROCO:8409) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$25.02, compared to a current price of NT$18.05 — trading 27.9% below its estimated fair value. The current Earnings Yield (Joel Greenblatt) % is 6.36% and 62.2% above the Healthcare Providers & Services industry median of 3.92. EBM Technologies' overall GF Score™ is 63/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings Yield (Joel Greenblatt) % calculated?
Earnings Yield (Joel Greenblatt) % is calculated from a company's financial statements. For EBM Technologies (ROCO:8409), the current Earnings Yield (Joel Greenblatt) % is 6.36% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is EBM Technologies (ROCO:8409) Overvalued in 2026?
Based on GuruFocus' analysis, EBM Technologies stock appears to be undervalued.
The current stock price of NT$18.05 is trading 27.9% below its estimated GF Value™ of NT$25.02.
GuruFocus considers EBM Technologies to be Modestly Undervalued.
Key valuation signals for ROCO:8409:
Earnings Yield (Joel Greenblatt) %: 6.36%
GF Value™: NT$25.02 vs. price of NT$18.05 (27.9% below fair value)
Industry Position: 62.2% above the Healthcare Providers & Services median (#189 of 681)
No single metric tells the full story. See the ROCO:8409 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
EBM Technologies Inc is engaged in picture archiving and communication systems. Its products include EBM diagnostic and reviewing station, EBM storage and utility server, and EBM breast imaging for PACS. The company develops and markets medical information technology solutions; and provides to the health sector.
63GF Score
Get the complete analysis for ROCO:8409
Earnings Yield (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:8409 has been successfully added to your 
